Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo: Results form a randomised, double-blind, phase 3 study.

Belani CP, Brodowicz T, Ciuleanu TE, Krzakowski M, Yang SH, Franke F, Cucevic B, Madhavan J, Santoro A, Ramlau R, Liepa AM, Visseren-Grul C, Peterson P, John WJ, Zielinski CC.

Lancet Oncol. 2012 Mar;13(3):292-9. doi: 10.1016/S1470-2045(11)70339-4. Epub 2012 Feb 14

SCA Istanbul 2012 CECOG experts’ recommendations on the use of denosumab in the prevention of skeletal-related events in bone metastases of lung cance

Wolfgang Hilbe · Ufuk Abacioglu · Daniel M. Aebersold · Mounir Bachouchi · Thomas Brodowicz · Rabab Gaafar · Gerold Holzer · Andrea Mohn-Staudner · Dimitar Kalev · Ewa Kalinka-Warzocha · Viljem Kovac · Marco Siano · Fulden Yumuk · Lilla Tamasi

MEMO published online 18.6.2013

Rationale for targeting the immune system through checkpoint molecule blockade in the treatment of non-small-cell lung cancer

NCBI Link

C. Zielinski, S. Knapp, C. Mascaux  & F. Hirsch

Download: Annals of Oncology 00: 1–9, 2013

Maintenance therapy in NSCLC

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

Tudor Ciuleanu MD, Thomas Brodowicz MD, Prof Christoph Zielinski MD, Joo Hang Kim MD, Prof Maciej Krzakowski MD, Eckart Laack MD, Prof Yi-Long Wu MD, Isabel Bover MD, Stephen Begbie MD, Valentina Tzekova MD, Branka Cucevic MD, Jose Rodrigues Pereira MD, Sung Hyun Yang MD, Jayaprakash Madhavan MD, Katherine P Sugarman MD, Patrick Peterson PhD, William J John MD, Kurt Krejcy MD, Dr Chandra P Belani MD.

Lancet 2009; 374; Issue 9699, Pages 1432-1440, 24 October 2009

Maintenance pemetrexed plus best supportive care (BSC) versus placebo plus BSC: A phase III study.

T. Ciuleanu, T. Brodowicz, CP. Belani, JH Kim. M. Krzakowski, E. Laack, YL. Wu, P. Peterson, S. Adachi, C. Zielinski

J. Clin. Oncol (supplement to 26) 2008: # 8011

Tolerability of pemetrexed versus placebo as a maintenance therapy in advanced non-Small Cell Lung Cancer: Evidence from a large randomized study.

C. Zielinski, S. Yang, A. Santoro, R. Ramlau, A. Liepa, P. Peterson, T. Brodowicz, J. Madhavan, F. Franke, B. Cucevic

J. Clin. Oncol (supplement to 26) 2008: # 8060

Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial.

Brodowicz T, Krzakowski M, Zwitter M, Tzekova V, Ramlau R, Ghilezan N, Ciuleanu T, Cucevic B, Gyurkovits K, Ulsperger E, Jassem J, Grgic M, Saip P, Szilasi M, Wiltschke C, Wagnerova M, Oskina N, Soldatenkova V, Zielinski C, Wenczl M; Central European Cooperative Oncology Group CECOG.

Lung Cancer. 2006 May; 52(2): 155-63. Epub 2006 Mar 29.

Gemcitabine and Cisplatin (GC) +/- Subsequent Maintenance Therapy with Single-Agent Gemcitabine in Advanced Non-small Cell Lung Cancer (NSCLC): Preliminary Results of a Randomized Trial of the Central European Cooperative Oncology Group (CECOG).

M. Krzakowski, M. Wenczl, T. Brodowicz, V. Tzekova, R. Ramlau, N. Ghilezan, B. Cucevic, E. Ulsperger, C. Zielinski, M. Zwitter.

Proc. Am. Soc. Clin. Oncol. 2004

Delay in time to worsening of symptoms of advanced non-small cell lung cancer patients using gemcitabine maintenance therapy.

P. Peterson, M. Zwitter, M. Krzakowski, M. Wenczl, V. Tzekova, R. Ramlau, T. Ciuleanu, A. Liepa, C. Zielinski, T. Brodowicz

Supplement to Journal of Clin. Oncol. 2006, 24, 399s, abstract 7140

Consensus on Medical Treatment of Non-Small-Cell Lung Cancer

Central European Cooperative Oncology Group(CECOG); Advisory Committee on Collaboration with Industry in Medical Education of the European School of Oncology (ESO); Vienna Medical Association.

Lung Cancer. 2002 Dec; 38 Suppl 3:S3-7

Consensus on Medical Treatment of Non-Small-Cell Lung Cancer – Update 2004

Lung Cancer (2005) 50, 129-137

Third CECOG Consensus on the Systemic Treatment of Non-Small-Cell Lung Cancer.

Brodowicz T, Ciuleanu T, Crawford J, Filipits M, Fischer JR, Georgoulias V, Gridelli C, Hirsch FR, Jassem J, Kosmidis P, Krzakowski M, Manegold C, Pujol JL, Stahel R, Thatcher N, Vansteenkiste J, Minichsdorfer C, Zöchbauer-Müller S, Pirker R, Zielinski CC; for the Central European Cooperative Oncology Group (CECOG).

Ann Oncol. 2011 Sep 22 (Epub ahead of print)

For publications of the results of the Consensus Conferenences
see Consensus Statements »

Prof. Zielinski on Publications

CECOG Contact Information

Please feel free to contact us if you have any questions.

  • by phone: +43/1/409 77 25

  • christiane.thallinger@cancer-center.cc

  • or fill in the form on contact page

CECOG Summer School